In this podcast, Monica Aggarwal, MD, explains the lifestyle modifications that are key for the prevention of cardiovascular disease and how clinicians can encourage their patients to make the...
Michael Blaha, MD, MPH, discusses his team’s study on whether troponin levels and coronary artery calcium score can predict future atherosclerotic cardiovascular disease risk, the use of aspirin and statins...
One of the many benefits of statins is their use as a primary prevention for cardiovascular disease. In this Q&A, Jiang Bian, PhD, and Yi Guo, PhD, answered our questions about the associations of...
Hookah is a common tobacco product, especially among youth. A research team aimed to better understand the effects of hookah on thrombogenesis. Lead author Fadi Khasawneh, B.Pharm, PhD, answered our...
In this video, Andrew Freeman, MD, leads a panel discussion around nutritional counseling in the cardiology clinic. Panelists include Emilio Ros, MD, PhD; Monica Aggarwal, MD; Robert Ostfeld, MD, MSc; James...
In part 5 of our series on lipid management, Paul Jellinger, MD, MACE, highlights the importance of coronary artery calcium score as a risk factor for ASCVD and its role in diagnosis and treatment of...
In part 2 of our series on lipid management, Dr Paul Jellinger explains the answer to the quiz question from part 1, the AACE lipid guidelines, and the role of renal disease in managing this patient. ...
New data are shedding light on the use of NOACs among patients with atrial fibrillation and obesity. Robert Giugliano, MD, explains how he hopes the new research will impact future guideline updates.
In this video, David Conen, MD, MPH, provides insight into the results of the Swiss Atrial Fibrillation Cohort (Swiss-AF) trial and what they reveal about the incidence of clinically silent brain infarcts...
